These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26202927)

  • 1. Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.
    Cervera N; Carbuccia N; Garnier S; Guille A; Adélaïde J; Murati A; Vey N; Mozziconacci MJ; Chaffanet M; Birnbaum D; Gelsi-Boyer V
    Leukemia; 2016 Apr; 30(4):966-70. PubMed ID: 26202927
    [No Abstract]   [Full Text] [Related]  

  • 2. Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma.
    Li Z; Stölzel F; Onel K; Sukhanova M; Mirza MK; Yap KL; Borinets O; Larson RA; Stock W; Sasaki MM; Joseph L; Raca G
    Leukemia; 2015 Oct; 29(10):2113-6. PubMed ID: 25787914
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.
    Grossmann V; Bacher U; Haferlach C; Schnittger S; Pötzinger F; Weissmann S; Roller A; Eder C; Fasan A; Zenger M; Staller M; Kern W; Kohlmann A; Haferlach T
    Leukemia; 2013 Sep; 27(9):1940-3. PubMed ID: 23648669
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.
    Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH
    Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
    Malmberg EB; Ståhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
    Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
    Cigudosa JC; Odero MD; Calasanz MJ; Solé F; Salido M; Arranz E; Martínez-Ramirez A; Urioste M; Alvarez S; Cervera JV; MacGrogan D; Sanz MA; Nimer SD; Benitez J
    Genes Chromosomes Cancer; 2003 Apr; 36(4):406-12. PubMed ID: 12619165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
    Goldberg SL; Noel P; Klumpp TR; Dewald GW
    Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5q-anomaly in a patient with erythroleukemia (M6-FAB classification).
    Donti E; Mecucci C; Rosetti A; Tabilio A; Venti G
    Haematologica; 1985; 70(5):424-7. PubMed ID: 3937779
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
    Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
    Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.
    Cervera N; Carbuccia N; Mozziconacci MJ; Adélaïde J; Garnier S; Guille A; Murati A; Chaffanet M; Vey N; Birnbaum D; Gelsi-Boyer V
    Blood Cancer J; 2017 Aug; 7(8):e594. PubMed ID: 28841205
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.
    Antony-Debré I; Duployez N; Bucci M; Geffroy S; Micol JB; Renneville A; Boissel N; Dhédin N; Réa D; Nelken B; Berthon C; Leblanc T; Mozziconacci MJ; Favier R; Heller PG; Abdel-Wahab O; Raslova H; Latger-Cannard V; Preudhomme C
    Leukemia; 2016 Apr; 30(4):999-1002. PubMed ID: 26316320
    [No Abstract]   [Full Text] [Related]  

  • 13. [Picture in clinical hematology no. 38: pure erythroid leukemia].
    Nakamura K; Dan K
    Rinsho Ketsueki; 2009 Jun; 50(6):445. PubMed ID: 19571502
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute erythroblastic leukemia. Cytological, cytogenetic and phenotypic studies in one case.
    Soler J; Pujol-Moix N; Bosch MA; Guanyabens C; Aventin A; Boque C; Brunet S
    Acta Haematol; 1989; 82(2):102-5. PubMed ID: 2508392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
    Takai K; Sanada M; Shibuya H
    Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pure erythroleukemia: a case report and literature review.
    Latif N; Salazar E; Khan R; Villas B; Rana F
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):283-90. PubMed ID: 20505651
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial acute myeloid leukemia and DiGuglielmo syndrome.
    Siebert R; Jhanwar S; Brown K; Berman E; Offit K
    Leukemia; 1995 Jun; 9(6):1091-4. PubMed ID: 7596175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplication of part of the short arm of A1 in a case of erythroleukemia (M6).
    Turchini MF; Travade P; Geneix A; de Larocque A; Beytout J; Malet P
    Pathologica; 1985; 77(1051):563-6. PubMed ID: 3870215
    [No Abstract]   [Full Text] [Related]  

  • 20. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.